Literature DB >> 2145495

Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review.

A H Rijpkema1, A A van der Sanden, A H Ruijs.   

Abstract

There are strong indications that post-menopausal oestrogen replacement therapy has a protective effect on the cardiovascular system, due to changes in the lipid profile. There are also indications that the addition of progestogens to oestrogen therapy may negatively influence these effects on the lipid metabolism. The present survey was undertaken to provide a comprehensive summary of all the available data on the effect of combined oestrogen-progestogen treatment on the post-menopausal lipid profile published from 1984 onwards. It appears that many progestogens are capable of diminishing the beneficial changes induced by oestrogens. The ultimate effect depends on the type and daily dose of both the oestrogen and the progestogen component. Oestradiol or oestradiol valerate administered cyclically with progesterone or cyproterone acetate appear to have the most favourable impact on lipids and lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145495     DOI: 10.1016/0378-5122(90)90007-s

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  17 in total

Review 1.  Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

Authors:  R H Foster; J A Balfour
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  Comparison of the effects of fetal hypothyroidism on glucose tolerance in male and female rat offspring.

Authors:  Fatemeh Bagheripuor; Mahboubeh Ghanbari; Saleh Zahediasl; Asghar Ghasemi
Journal:  J Physiol Sci       Date:  2015-02-04       Impact factor: 2.781

3.  Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.

Authors:  M Stomati; B Hartmann; A Spinetti; D Mailand; S Rubino; A Albrecht; J Huber; F Petraglia; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

Review 4.  Cardiovascular pharmacology of hormone replacement therapy.

Authors:  G M Rosano; G Panina
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

5.  Serum metabolomic profiles associated with postmenopausal hormone use.

Authors:  Victoria L Stevens; Ying Wang; Brian D Carter; Mia M Gaudet; Susan M Gapstur
Journal:  Metabolomics       Date:  2018-07-06       Impact factor: 4.290

6.  Variations in lipid levels according to menstrual cycle phase: clinical implications.

Authors:  Sunni L Mumford; Sonya Dasharathy; Anna Z Pollack; Enrique F Schisterman
Journal:  Clin Lipidol       Date:  2011-04-01

7.  17β-estradiol increases expression of the oxidative stress response and DNA repair protein apurinic endonuclease (Ape1) in the cerebral cortex of female mice following hypoxia.

Authors:  Alicia K Dietrich; Gwendolyn I Humphreys; Ann M Nardulli
Journal:  J Steroid Biochem Mol Biol       Date:  2013-07-29       Impact factor: 4.292

Review 8.  Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels.

Authors:  A K Mantel-Teeuwisse; J M Kloosterman; A H Maitland-van der Zee; O H Klungel; A J Porsius; A de Boer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

9.  Systemic effects of vaginally administered estrogen therapy: a review.

Authors:  Megan Krause; Thomas L Wheeler; Holly E Richter; Thomas E Snyder
Journal:  Female Pelvic Med Reconstr Surg       Date:  2010-05       Impact factor: 2.091

10.  The impact of D-Trp6 LH-RH on plasma lipid levels.

Authors:  G A Goldman; A Schoenfeld; J Ovadia; B Fisch
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.